Who is eligible for clinical trial NCT06087744?

Participants must meet protocol criteria for Neurodevelopmental Disorders. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT06087744 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2024-04-17

NeuroN-QI: An Intervention to Promote Preterm Infants' Neurodevelopment (NCT06087744)

🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program Sponsor: St. Justine's Hospital

🩺 Plain-English Summary (8th-Grade Level)

NeuroN-QI aims to evaluate the effects of an intervention consisting of periods of: 1) parents/preterm infants skin-to-skin contact and auditory stimulation by the parents's voice and 2) calm without manipulation with olfactory stimulation with breast milk in the incubator/bed both combined with appropriate light and noise levels to promote neurodevelopment preterm infants.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (13 items).

Location: CHU Sainte-Justine — Montreal, Quebec

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

for preterm infants:
born between 24 and 33 6/7 weeks GA;
ready for SSC Inclusion criteria for mothers and fathers:
agree to do at least one SSC session/week combined with 10 min of auditory stimulation until 36 weeks of GA of their preterm infant;
mothers express breast milk for their preterm infants For twin births (twin pregnancies), fathers will also be invited to participate in the study, so that both infants can participate in the study.

Usually NOT eligible if any of the following apply:

Exclusion criteria for preterm infants:
congenital anomalies or genetic disorders
intraventricular hemorrhage \> grade II
are small for GA defined as birth weight \<10th percentile
on postnatal day 19 (maximum days targeted for study start)
are still receiving analgesics, sedatives, paralyzing agents
are under mechanical ventilation Exclusion criteria mothers and fathers:
are aged \<18 years;
have a physical condition that does not allow the SSC
abuse illicit substances or alcohol that could influence stress, anxiety and parent- child interactions
feed their preterm infant exclusively with commercial infant formula
mothers had a breast surgery that could influence their breast milk production

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (2 Sites)

CHU Sainte-Justine — Montreal, Quebec
CUSM — Montreal, Quebec

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗